Clincosm LogoSign in Get a demo

Diabetes Mellitus, Type 1

Showing NaN - NaN of 46
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 1 Trial in Worldwide (insulin icodec, insulin degludec, insulin aspart)

Completed
  • Diabetes Mellitus, Type 1
  • insulin icodec
  • +2 more
  • Concord, California
  • +98 more
Feb 2, 2023

Diabetes, Type 1, Noncompliance, Patient Trial in Dallas (Continuous Glucose Monitoring, Secure texting)

Recruiting
  • Diabetes Mellitus, Type 1
  • Noncompliance, Patient
  • Continuous Glucose Monitoring
  • Secure texting
  • Dallas, Texas
    UT Southwestern Medical Center
Sep 26, 2022

Diabetes, Type 1 Trial in United States (MYL-1501D product using manufacture process V, MYL-1501D product using manufacture

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • MYL-1501D product using manufacture process V
  • MYL-1501D product using manufacture process VI
  • Fresno, California
  • +37 more
Mar 1, 2022

Diabetes, Type 1 Trial in United States (MYL-1601D Product, FlexPen NovoLog®)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • MYL-1601D Product
  • FlexPen NovoLog®
  • Montgomery, Alabama
  • +157 more
Feb 23, 2022

TrialNet Pathway to Prevention of T1D

Recruiting
  • Diabetes Mellitus, Type 1
    • Orange, California
    • +21 more
    Feb 18, 2022

    Diabetes, Type 1 Diabetes, Diabetes, Type 1 Trial in United States (Bionic Pancreas)

    Completed
    • Diabetes Mellitus
    • +2 more
    • Bionic Pancreas
    • Orange, California
    • +15 more
    Jan 17, 2022

    Diabetes, Type 1 Trial in Belgium, United States (AG019 - Low Dose, Teplizumab, Placebo-AG019)

    Completed
    • Diabetes Mellitus, Type 1
    • AG019 - Low Dose
    • +5 more
    • Birmingham, Alabama
    • +17 more
    Nov 9, 2021

    Diabetes, Type 1 Trial in United States (TTP399, Placebo Oral Tablet)

    Completed
    • Diabetes Mellitus, Type 1
    • Beverly Hills, California
    • +14 more
    Nov 24, 2020

    Diabetes, Type 1 Trial in Worldwide (Gan & Lee Insulin Glargine Injection, Lantus®)

    Completed
    • Diabetes Mellitus, Type 1
    • Gan & Lee Insulin Glargine Injection
    • Lantus®
    • Birmingham, Alabama
    • +84 more
    Jul 7, 2020

    Diabetes, Type 1 Trial in Worldwide (Oral Insulin, Placebo)

    Completed
    Has Results
    • Diabetes Mellitus, Type 1
    • Oral Insulin
    • Placebo
    • San Francisco, California
    • +17 more
    Apr 27, 2020

    Diabetes, Type 1 Trial in Canada, United States (Parenteral Insulin, Close Observation, Oral Insulin)

    Completed
    • Diabetes Mellitus, Type 1
    • Parenteral Insulin
    • +3 more
    • Los Angeles, California
    • +14 more
    Apr 22, 2020

    Diabetes, Type 1 Trial in Worldwide (Gan & Lee Insulin Lispro Injection, Humalog)

    Withdrawn
    • Diabetes Mellitus, Type 1
    • Gan & Lee Insulin Lispro Injection
    • Humalog
    • Anaheim, California
    • +106 more
    Feb 2, 2020

    Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin aspart)

    Completed
    Has Results
    • Diabetes
    • Diabetes Mellitus, Type 1
    • Faster-acting insulin aspart
    • insulin aspart
    • Encino, California
    • +91 more
    Nov 12, 2019

    Diabetes, Type 1, Adolescent Behavior Trial in Dallas (Pet Fish)

    Completed
    • Diabetes Mellitus, Type 1
    • Adolescent Behavior
    • Pet Fish
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Sep 30, 2019

    Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin degludec, insulin detemir, insulin aspart)

    Completed
    Has Results
    • Diabetes
    • Diabetes Mellitus, Type 1
    • insulin degludec
    • +2 more
    • Little Rock, Arkansas
    • +80 more
    Jun 3, 2019

    Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin detemir, insulin aspart)

    Completed
    Has Results
    • Diabetes
    • Diabetes Mellitus, Type 1
    • Faster-acting insulin aspart
    • +2 more
    • Mobile, Alabama
    • +190 more
    May 28, 2019

    Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin aspart, insulin degludec)

    Completed
    Has Results
    • Diabetes
    • Diabetes Mellitus, Type 1
    • Faster-acting insulin aspart
    • +2 more
    • Tucson, Arizona
    • +151 more
    May 28, 2019

    Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin degludec/insulin aspart, insulin aspart, insulin detemir)

    Completed
    Has Results
    • Diabetes
    • Diabetes Mellitus, Type 1
    • insulin degludec/insulin aspart
    • +2 more
    • Phoenix, Arizona
    • +72 more
    Jun 3, 2019

    Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin aspart, insulin degludec)

    Completed
    Has Results
    • Diabetes
    • Diabetes Mellitus, Type 1
    • Faster-acting insulin aspart
    • +2 more
    • Phoenix, Arizona
    • +154 more
    May 22, 2019

    Diabetes, Type 1 Trial in United States (Insulin lispro, recombinant human hyaluronidase PH20, Insulin aspart)

    Completed
    Has Results
    • Diabetes Mellitus, Type 1
    • Insulin lispro
    • +4 more
    • Escondido, California
    • +18 more
    Feb 5, 2019

    Diabetes, Type 1 Trial in Worldwide (Empagliflozin, Placebo)

    Completed
    Has Results
    • Diabetes Mellitus, Type 1
    • Escondido, California
    • +130 more
    Dec 12, 2018

    Diabetes, Diabetes, Type 1 Trial in Poland, Puerto Rico, United States (insulin degludec, insulin glargine, insulin aspart)

    Completed
    Has Results
    • Diabetes
    • Diabetes Mellitus, Type 1
    • insulin degludec
    • +2 more
    • Birmingham, Alabama
    • +98 more
    Dec 7, 2018

    Diabetes, Type 1 Trial in Worldwide (Empagliflozin, Placebo)

    Completed
    Has Results
    • Diabetes Mellitus, Type 1
    • Montgomery, Alabama
    • +188 more
    Oct 31, 2018

    Diabetes, Diabetes, Type 1 Trial in Canada, United States (inhaled human insulin, insulin detemir, insulin aspart)

    Terminated
    • Diabetes
    • Diabetes Mellitus, Type 1
    • inhaled human insulin
    • +2 more
    • Birmingham, Alabama
    • +95 more
    Sep 3, 2018

    Diabetes, Type 1 Trial in Israel, United States (LY2605541, Insulin glargine)

    Completed
    Has Results
    • Diabetes Mellitus, Type 1
    • Chula Vista, California
    • +12 more
    Mar 17, 2018